跳至主要内容
临床试验/NCT01904812
NCT01904812已完成不适用

Longitudinal Study of Quality of Life and Activity in Systemic Lupus Erythematosus

Centre Hospitalier Universitaire Dijon1 个研究点 分布在 1 个国家目标入组 356 人开始时间: 2011年12月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
356
试验地点
1
主要终点
data for quality of life and satisfaction

研究概览

简要总结

Systemic lupus erythematosus is a complex disease whose evaluation in everyday practice and in clinical research requires several aspects to be taken into account, in particular the impact of disease activity on quality of life. To date, the effect of systemic lupus on quality of life has only been described using generic questionnaires. Among the specific questionnaires for systemic lupus, the LupusQol, which has been validated in French, shows interesting psychometric properties. The determinants of quality of life specifically related to the disease are still unknown and could be studied using a longitudinal cohort thanks to the French version of the LupusQol.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Health Services Research
盲法
None

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • - Patients meeting ACR 1997 classification criteria for systemic lupus erythematosus.
  • Patients able to understand written and spoken French.
  • Patients aged from 18 to 75 years
  • Patients who have received written and oral information about the research.

排除标准

  • - Patients aged less than 18 years
  • Patients aged more than 75 years
  • Severe mental retardation Any impairment of abilities to understand that make self-evaluation impossible

研究组 & 干预措施

Lupus erythematosus

Other

干预措施: Questionnaire about quality of life and satisfaction (Other)

结局指标

主要结局

data for quality of life and satisfaction

时间窗: participants will be followed for the duration of hospital stay, an expected average of 3 months

Quality of life and satisfaction will be evaluate by questionnaire as Questionnaire SLEQOL, QUESTIONNAIRE LUPUSQOL, QUESTIONNAIRE MFI-20

次要结局

  • Clinical data(participants will be followed for the duration of hospital stay, an expected average of 3 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验